A citrus flavonoid that doubles as a natural sweetener and has modest antioxidant properties. Provides natural sweetening and delivers citrus flavonoid antioxidants. Acts on NF-kB and COX-2 inflammatory pathways in preclinical studies.
Reviewed March 2026
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Neohesperidin has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Both carry the neohesperidose sugar that gives bitter citrus its taste and both need the same bacterial rhamnosidase to release the aglycone. They travel together in the same raw material.
Bergamot and other bitter citrus supply neohesperidin alongside naringin and neoeriocitrin. Stacking the two raises the same flavanone pool rather than adding a separate active.
Neohesperidin is absorbed only after gut bacteria strip its sugar and release hesperetin. Microbial rhamnosidase capacity is the step that decides how much reaches the blood, and it varies by the strains present.
Ascorbate reduces the oxidised phenolic form of the flavanone back to its active state. The two occur together naturally in citrus for the same reason.
Citrus flavonoids bind non-heme iron in the gut and lower how much of a mineral dose is absorbed. Spacing the two apart avoids the competition.
Neohesperidin is hesperetin 7-O-neohesperidoside and hesperidin is hesperetin 7-O-rutinoside, so both release the same aglycone, hesperetin, after the sugar is cleaved. Citrus extracts routinely contain both, and they converge on one circulating metabolite pool. The neohesperidoside linkage is the bitter one, which is why the two taste different despite the shared core.
Human intestinal enzymes do not cleave the alpha-rhamnosidic bond in neohesperidin, so the intact glycoside reaches the colon. Bacterial alpha-rhamnosidase and beta-glucosidase release hesperetin there, and only then can it be absorbed. Gut microbial capacity is therefore the rate-limiting step for exposure, and it varies widely between people.
Bifidobacteria carry glycoside hydrolases that strip sugar groups from dietary flavonoids in the colon. That step converts a poorly absorbed glycoside into an absorbable aglycone. This is a mechanism grounded in microbial enzymology rather than a measured combination outcome in people.
Absorbed flavonoid aglycones are rapidly glucuronidated and sulfated by UGT and SULT enzymes in the enterocyte and liver. Two flavonoids taken together draw on the same limited conjugation capacity, which can raise the unconjugated fraction of each. That is a change in metabolite handling, not a demonstrated increase in any effect.
Rutin is quercetin bound to the same rhamnose-glucose disaccharide family that neohesperidin carries, so both depend on bacterial rhamnosidase before absorption. Delivered together they load the same colonic enzyme step. Formulators pair them in citrus bioflavonoid blends for that reason.
Piperine slows UDP-glucuronosyltransferase activity in the intestinal wall, which is the main clearance route for flavonoid aglycones. Slower conjugation would be expected to leave more unconjugated hesperetin in circulation after a neohesperidin dose. The pairing is described for other polyphenols and has not been measured with neohesperidin, so this is a mechanistic expectation rather than a measured result.
Catechins and flavanones are both handled by intestinal sulfotransferases and glucuronosyltransferases. Given together, each slows the other's conjugation, shifting the ratio of free to conjugated metabolite. The consequence is on pharmacokinetics, a set of markers, not on any endpoint.
Neohesperidin dihydrochalcone and steviol glycosides are both intense sweeteners with lingering aftertastes of different character, and blending them lets a formulator use less of each. NHDC also masks bitterness at levels below its own sweetness threshold. This is a taste-system interaction with no nutritional component.
Nothing specific on file for Neohesperidin. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
These are the studies our verdict leans on, chosen from the 1 we read for Neohesperidin. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.